Share:  
|
PAGE
MENU

EMPOWER

EMPOWER is a multi-centre, double-masked, randomised controlled trial designed to determine if the administration of Domperidone compared to placebo will increase breast milk production without any signs of harm over a two or four week period.

The primary research question asks: In mothers of preterm infants 231/7 to 296/7 completed weeks gestation at birth who are pumping to provide expressed breast milk for their infant(s) and are identified as having an inadequate milk supply, does the administration of Domperidone compared to placebo increase breast milk volume without any signs of harm over a two or four week period?

The sample size for EMPOWER is 560 mothers (280/group), to be recruited from 14 centres across Canada

For more information on the EMPOWER trial, please contact: empower@sunnybrook.ca.